Cerebrasol Canada Ltd is a contract research organisation (CRO) which was established to provide high quality highly specialised translational neuroscience research services to the biopharmaceutical industry. Our global clientele ranges from small, “start-up” biotechnology companies to major, multinational pharmaceutical establishments.
Professor David Spanswick
David is CSO of Cerebrasol, NeuroSolutions and Pacific Discovery Services. He has over 30 years of experience in electrophysiology and neuroscience. He graduated from the University of East Anglia, UK in 1986 (B.Sc). He then obtained his PhD at University of Birmingham, studying neurophysiology. Prior to establishment of Cerebrasol, Prof. Spanswick acted as a consultant to a number of multinational pharmaceutical companies. Prof. Spanswick is the author of over 50 academic publications in his area of expertise. In addition to his role as Chief Scientific Officer with Cerebrasol Canada Ltd, Dave was appointed a senior lecturer, University of Warwick in 2000 and Professor of Molecular Neuroscience at Warwick Medical School in 2004. In 2011 Dave joined the Department of Physiology at Monash University.
Dr Fei-Yue Zhao
Fei-Yue is Head of Pain Research for Cerebrasol, Neurosolutions and Pacific Discovery Services, having worked previously in laboratories in the UK and Japan. Dr Zhao has over 30 years’ experience in system electrophysiology and had worked in multiple drug discovery programs in the pain area since 1999. Prior to joining Cerebrasol, Dr Zhao was head of system electrophysiology at Parke Davis/Pfizer in Cambridge, UK where he worked on the site and mechanism of action of Gabapentin.